tiprankstipranks
Trending News
More News >
Advertisement

STXV - ETF AI Analysis

Compare

Top Page

STXV

Strive 1000 Value ETF (STXV)

Rating:71Outperform
Price Target:
STXV, the Strive 1000 Value ETF, earns a solid overall rating largely because several of its bigger positions—like Merck, Micron, Johnson & Johnson, and Wells Fargo—combine strong financial performance with positive earnings outlooks and strategic growth plans. These strengths are partly offset by holdings such as Chevron, AbbVie, and Procter & Gamble, where issues like weaker technical trends, financial stability concerns, and valuation challenges weigh on the fund. The main risk factor is its meaningful exposure to a few large value names in sectors like energy and healthcare, where company-specific or sector pressures could impact overall results.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Leading Holdings
Several of the largest positions, including major energy, health care, and technology names, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector Diversification
Holdings are spread across many sectors such as financials, health care, technology, energy, and others, which helps reduce the impact if any one industry struggles.
Negative Factors
Heavy U.S. Concentration
The fund is invested almost entirely in U.S. companies, offering very limited geographic diversification outside the United States.
Weakness in Some Top Financial Holdings
Several large financial stocks in the top holdings have shown weak year-to-date performance, which can drag on overall returns if the sector stays under pressure.
Moderate Fund Size
With a relatively modest asset base, the ETF may be less liquid than larger, more established value funds, which could matter for investors trading bigger amounts.

STXV vs. SPDR S&P 500 ETF (SPY)

STXV Summary

The Strive 1000 Value ETF (STXV) tracks the Bloomberg US 1000 Value Index, focusing on large U.S. companies that appear undervalued based on their fundamentals. It owns a wide mix of sectors like financials, health care, and energy, with well-known names such as Exxon Mobil and Johnson & Johnson among its top holdings. Investors might consider this ETF for broad diversification across many established companies and potential long-term growth plus dividends from value stocks. A key risk is that value stocks can fall out of favor and the ETF’s price can go up and down with the overall stock market.
How much will it cost me?The Strive 1000 Value ETF (Ticker: STXV) has an expense ratio of 0.18%, which means you’ll pay $1.80 per year for every $1,000 invested. This is lower than the average for actively managed funds because it is passively managed, tracking an index of large-cap value stocks.
What would affect this ETF?The Strive 1000 Value ETF could benefit from a favorable economic environment that supports value investing, such as rising interest rates, which often boost financial sector performance, or increased demand for energy and healthcare services, given its significant exposure to these sectors. However, challenges like regulatory changes affecting top holdings like Exxon Mobil or Johnson & Johnson, or economic slowdowns that impact consumer spending and cyclical sectors, could negatively affect the ETF's performance.

STXV Top 10 Holdings

STXV leans heavily into classic U.S. value territory, with big banks and health care names setting the tone. Micron has been the surprise engine, surging on AI-related optimism and giving the fund a tech-powered boost despite its value label. Exxon and Chevron are also pulling their weight as energy stays in favor, adding some fuel to returns. On the flip side, UnitedHealth is losing steam, and banks like Bank of America and Wells Fargo have been more mixed, keeping overall performance solid but not spectacular.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Exxon Mobil3.77%$2.81M$656.64B36.55%
74
Outperform
Chevron2.26%$1.68M$396.30B23.11%
71
Outperform
Bank of America1.92%$1.43M$336.08B10.94%
72
Outperform
Johnson & Johnson1.78%$1.33M$571.82B44.97%
78
Outperform
UnitedHealth1.56%$1.16M$258.08B-42.92%
72
Outperform
Berkshire Hathaway B1.44%$1.07M$1.05T-7.77%
66
Neutral
AbbVie1.43%$1.06M$368.38B-1.84%
66
Neutral
Procter & Gamble1.32%$981.93K$340.95B-12.97%
69
Neutral
Goldman Sachs Group1.27%$948.16K$239.03B46.26%
73
Outperform
Merck & Company1.20%$894.81K$283.09B21.78%
80
Outperform

STXV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
35.63
Negative
100DMA
34.22
Positive
200DMA
32.64
Positive
Market Momentum
MACD
-0.20
Positive
RSI
35.95
Neutral
STOCH
27.55
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For STXV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 35.94, equal to the 50-day MA of 35.63, and equal to the 200-day MA of 32.64, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 35.95 is Neutral, neither overbought nor oversold. The STOCH value of 27.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for STXV.

STXV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$74.72M0.18%
71
Outperform
$85.52M0.49%
73
Outperform
$84.50M0.29%
70
Neutral
$81.28M0.75%
75
Outperform
$71.25M0.55%
70
Outperform
$70.94M0.50%
72
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
STXV
Strive 1000 Value ETF
34.94
5.11
17.13%
DVAL
BrandywineGLOBAL - Dynamic US Large Cap Value ETF
SPDV
AAM S&P 500 High Dividend Value ETF
MAVF
Matrix Advisors Value ETF
DHLX
Diamond Hill Large Cap Concentrated ETF
ITAN
Sparkline Intangible Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement